Cargill adds excipient for ODT formulations at CPhI
Cargill is using CPhI 2010 to launch a formulation of its Zerose erythritol excipient for use in orally disintegrating tablets (ODT).
Cargill is using CPhI 2010 to launch a formulation of its Zerose erythritol excipient for use in orally disintegrating tablets (ODT).
SAFC has completed the expansion of its manufacturing plant in Jerusalem, Israel, further increasing its global footprint.
Accucaps has added a Speciality Products Centre to support clients' high potency liquid filled soft gel formulation needs.
BioNano Consulting (BNC) predicts impending patent loss will accelerate adoption of nanotechnology in drug formulation and head to US to boost US business.
Horizon Discovery has acquired Hypoxium and launched Horizon Discovery Services, to provide “a new wave” in oncology drug development.
Mark Weinstein, CEO of Bioclinica, has hit back at a public letter from Nicusa Capital CEO, Paul Johnson, claiming that the company's corporate strategy is 'flawed' and demanding the resignation of three top executives.
GlaxoSmithKline has told its workforce that 55 jobs will be axed at its manufacturing base in Currabinny, Co Cork, and 66 jobs will be lost as a result of revised shift-working plans.
China leads the field in 'potential future' API suppliers, positioning it to become a dominant force as these companies develop, Thomson Reuters said at CPhI 2010.
Novo Nordisk is investing $73m in the expansion of its manufacturing facility in Clayton, North Carolina, to make room for increased production capacity for the biopharma giant’s insulin delivery services.